America Partners With Butler Schein Animal Health to Distribute

World’s Leading Animal Stem Cell Technology to U.S. Veterinarians

Global leader in animal stem cell technology is poised for significant

expansion through new partnership with top U.S. companion animal health

distribution company

Las Vegas, Nevada (PRWEB) February 22, 2012

MediVet-America, the global leader in veterinary stem cell technology

and regenerative medicine, has entered into a distribution partnership

with Butler Schein Animal Health, a division of Henry Schein, the

leading companion animal health distribution company in the U.S., to

sell and distribute stem cell kits and equipment to veterinarians

serving the nation’s fast-growing $50 billion pet industry.

The announcement was made today at the Western Veterinary Conference in Las Vegas by Jeremy Delk, CEO of MediVet-America.

The two companies will partner to sell and distribute MediVet-America’s

advanced stem cell technology to more than 26,000 veterinary clinics

nationwide. Adult animal stem cell technology uses the body’s own

regenerative healing power to help treat dogs, cats, horses and other

animals suffering from painful arthritis, hip dysplasia and tendon,

ligament and cartilage injuries and other ailments.

The Adipose-Derived Stem Cell Procedure Kit and state of the art

equipment, co-developed with Medical Australia, enable veterinarians to

remove a small sample of fat, separate the stem cells, then activate an